Medical Device Network on MSN6d
Newronika’s DBS device gains CE Mark approval for Parkinson’s treatmentNewronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe. This closed-loop deep brain stimulation (DBS) device claims to adjust the ...
Newronika announced today that it received CE mark approval for its AlphaDBS device for treating Parkinson's disease.
The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...
Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has ...
Newronika has received an investigational device exemption (IDE) for its adaptive deep brain stimulation (DBS) system from the US Food and Drug Administration (FDA), allowing it to begin a pivotal ...
Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform
MILAN, Feb. 13, 2025 /PRNewswire/ -- Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 million Series B funding round.
MILAN, Feb. 5, 2025 /PRNewswire/ -- Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption ...
Newronika has secured CE Mark approval for its AlphaDBS device aimed at the treatment of Parkinson's disease (PD), in Europe. This closed-loop deep brain stimulation (DBS) device claims to adjust ...
MILAN, March 24, 2025 /PRNewswire/ -- Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback